NCT06355154

Brief Summary

Diabetes during pregnancy increases maternal and fetal complications, necessitating optimal glycemic control. The standard care diet (SCD, ≥175g/day carbohydrate) lacks robust evidence, particularly for pregnancies requiring intensive insulin treatment (IIT). This RCT investigates whether a moderate carbohydrate diet (MCD, ≤120g/day) versus SCD improves glycemic control and alters metabolomic profiles in pregnant individuals on IIT. Aims: To compare the efficacy and safety of a SCD versus MCD on glycemic control, metabolomic signatures, and pregnancy outcomes in pregnant individuals on IIT.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
21mo left

Started May 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress53%
May 2024Feb 2028

First Submitted

Initial submission to the registry

March 28, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 9, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

May 28, 2024

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2027

Expected
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2028

Last Updated

October 2, 2025

Status Verified

September 1, 2025

Enrollment Period

2.9 years

First QC Date

March 28, 2024

Last Update Submit

September 29, 2025

Conditions

Keywords

Diabetes in pregnancyGlycemic balanceLow CarbohydratesTime in rangeKetosis

Outcome Measures

Primary Outcomes (2)

  • Time in range

    Percentage of time during the day that the patient is in the normal range of glucose balance in pregnancy

    24 hours

  • Time above range

    Percentage of time during the day that the patient is above the normal range of glucose balance in pregnancy

    24 hours

Study Arms (2)

The Standard of Care diet

NO INTERVENTION

(a diet that includes at least 175 grams of carbohydrates per day or more/ \>40% CHO, SCD)

The moderate carbohydrate diet

EXPERIMENTAL

(a diet with 120 grams of carbohydrates and customized according to pregnancy requirements/ \<40% CHO, MCD)

Other: Nutritional intervention

Interventions

The intervention will contain a diet with a reduced amount of carbohydrates compared to the standard treatment today but without caloric restriction.

The moderate carbohydrate diet

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Pregnant women with singleton pregnancies.
  • Over 18 years old.
  • Diagnosis of GDM- 3-h 100-g OGTT according to the American College of Obstetricians and Gynecologists supported by the American Diabetes Association, Or Diagnosis of type 1 or 2 diabetes before pregnancy, Or Diagnosis of early GDM by either OGTT in the first trimester or elevated blood glucose measurements in the fasting (above 95mg/dl) or the postprandial (above 140 mg/dl) state.
  • Are already on or intended to start intensive insulin treatment (at leased 2 injections of insulin per day) or wear an insulin pump.
  • Are willing to wear a continuous glucose monitoring system.
  • BMI of 18.5-42 kg/m2 at the time of diagnosis.

You may not qualify if:

  • Individual with risk factors for:
  • Placental insufficiency.
  • Hypertension.
  • Renal disease.
  • Thrombophilia
  • Rheumatologic disease.
  • A history of preeclampsia, or fetal growth restriction (IUGR).
  • Individuals with a history of preterm labor, or concomitant therapy with β-blockers or glucocorticoids.
  • Individuals who smoke and/or consume any amount of alcohol during pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hadassah Hospital

Jerusalem, Israel

RECRUITING

Related Publications (12)

  • Vounzoulaki E, Khunti K, Abner SC, Tan BK, Davies MJ, Gillies CL. Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis. BMJ. 2020 May 13;369:m1361. doi: 10.1136/bmj.m1361.

    PMID: 32404325BACKGROUND
  • Petry CJ. Gestational diabetes: risk factors and recent advances in its genetics and treatment. Br J Nutr. 2010 Sep;104(6):775-87. doi: 10.1017/S0007114510001741. Epub 2010 May 21.

    PMID: 20487576BACKGROUND
  • McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019 Jul 11;5(1):47. doi: 10.1038/s41572-019-0098-8.

    PMID: 31296866BACKGROUND
  • Sweeting A, Wong J, Murphy HR, Ross GP. A Clinical Update on Gestational Diabetes Mellitus. Endocr Rev. 2022 Sep 26;43(5):763-793. doi: 10.1210/endrev/bnac003.

    PMID: 35041752BACKGROUND
  • ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Jeffrie Seley J, Stanton RC, Gabbay RA, on behalf of the American Diabetes Association. 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes-2023. Diabetes Care. 2023 Jan 1;46(Suppl 1):S254-S266. doi: 10.2337/dc23-S015.

    PMID: 36507645BACKGROUND
  • lD Meyers, JP Hellwig JO. Institute of Medicine. Dietary Reference Intakes: The Essential Guide to Nutrient Requirements. 2006.

    BACKGROUND
  • Sweeting A, Mijatovic J, Brinkworth GD, Markovic TP, Ross GP, Brand-Miller J, Hernandez TL. The Carbohydrate Threshold in Pregnancy and Gestational Diabetes: How Low Can We Go? Nutrients. 2021 Jul 28;13(8):2599. doi: 10.3390/nu13082599.

    PMID: 34444759BACKGROUND
  • Tanner HL, Ng HT, Murphy G, Barrett HL, Callaway LK, McIntyre HD, Nitert MD. Habitual carbohydrate intake is not correlated with circulating beta-hydroxybutyrate levels in pregnant women with overweight and obesity at 28 weeks' gestation. Diabetologia. 2024 Feb;67(2):346-355. doi: 10.1007/s00125-023-06044-w. Epub 2023 Nov 16.

    PMID: 37971504BACKGROUND
  • Mijatovic J, Louie JCY, Buso MEC, Atkinson FS, Ross GP, Markovic TP, Brand-Miller JC. Effects of a modestly lower carbohydrate diet in gestational diabetes: a randomized controlled trial. Am J Clin Nutr. 2020 Aug 1;112(2):284-292. doi: 10.1093/ajcn/nqaa137.

    PMID: 32537643BACKGROUND
  • Shalit1 R, Dayan2 N, Yoeli-Ullman2 R, , T. Cukierman-Yaffe1 3; The relationship between low carbohydrate diet and pregnancy outcomes in women with pre_gestational diabetes: a historical prospective study. EASD [Internet]. Barcelona; 2019. Available from: https://www.easd.org/media-centre/home.html#!resources/the-relationship-between-low-carbohydrate-diet-and-pregnancy-outcomes-in-women-with-pre-gestational-diabetes-a-historical-prospective-study

    BACKGROUND
  • Peterson CM, Jovanovic-Peterson L. Percentage of carbohydrate and glycemic response to breakfast, lunch, and dinner in women with gestational diabetes. Diabetes. 1991 Dec;40 Suppl 2:172-4. doi: 10.2337/diab.40.2.s172.

    PMID: 1748252BACKGROUND
  • Major CA, Henry MJ, De Veciana M, Morgan MA. The effects of carbohydrate restriction in patients with diet-controlled gestational diabetes. Obstet Gynecol. 1998 Apr;91(4):600-4. doi: 10.1016/s0029-7844(98)00003-9.

    PMID: 9540949BACKGROUND

MeSH Terms

Conditions

Diabetes, GestationalKetosis

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAcidosisAcid-Base Imbalance

Central Study Contacts

Genya Aharon Hananel, DR MD PHD

CONTACT

naama shirazi, mrs

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Open label, randomized controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 28, 2024

First Posted

April 9, 2024

Study Start

May 28, 2024

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

February 1, 2028

Last Updated

October 2, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations